CD82 and cancer: Despite the lack of full understanding of the underlying mechanisms of the function of KAI1 in inhibiting metastasis of cancer cells, attempts have been made in order to use KAI1 in therapeutic strategies to treat cancer patients (Tonoli and Barrett, 2005).